Delaware
|
11-2920559
|
(State
of incorporation)
|
(I.R.S.
Employer Identification No.)
|
Securities
registered pursuant to Section 12(b) of the Act:
|
NONE
|
|
Securities
registered pursuant to Section 12(g) of the Act:
|
Common Stock, $.001 par
value
|
Large
accelerated filer
£
|
Accelerated
filer
£
|
Non
- accelerated filer
£
|
Smaller
reporting company
T
|
Item
Number
|
Page
Number
|
|
PART
I
|
||
1.
|
1
|
|
1A.
|
9
|
|
1B
|
13
|
|
2.
|
13
|
|
3.
|
13
|
|
4.
|
13
|
|
PART
II
|
||
5.
|
14
|
|
6.
|
14
|
|
7.
|
15
|
|
7A.
|
23
|
|
8.
|
23
|
|
9.
|
23
|
|
9A
(T).
|
24
|
|
9B.
|
25
|
|
PART
III
|
||
10.
|
26
|
|
11.
|
30
|
|
12.
|
35
|
|
13.
|
37
|
|
14.
|
38
|
|
PART
IV
|
||
15.
|
39
|
|
43
|
||
F-1
|
Item
1.
|
Business
|
·
|
Business Process
Outsourcers
- use our Cicero
®
solution in
contact centers to provide real time integration among existing
back-office systems, eliminate redundant data entry, shorten call times,
provide real-time data access and enhance customer service and service
levels.
|
·
|
A financial institution
- uses our Cicero
®
solution to
provide real-time integration among market data, customer account
information, existing back-office systems and other legacy applications,
eliminate redundant data entry, provide real-time data access and
processing, and enhance customer service and service
levels.
|
·
|
An insurance company
-
uses our Cicero
®
solution to
integrate their customer information systems with over thirty software
applications including a CRM
application.
|
·
|
A law enforcement
organization
- uses our Cicero
®
solution to
streamline and automate support for arrests and investigations while
merging federal, state and local systems within a unified
process.
|
·
|
Product
functionality and features;
|
·
|
Availability
and quality of support services;
|
·
|
Ease
of product implementation;
|
·
|
Price;
|
·
|
Product
reputation; and
|
·
|
Our
financial stability.
|
·
|
Portal
software offers the ability to aggregate information at a single point,
but not the ability to integrate transactions from a myriad of information
systems on the desktop. Plumtree is a representative company in
the market.
|
·
|
Middleware
software provides integration of applications through messages and data
exchange implemented typically in the middle tier of the application
architecture. This approach requires modification of the
application source code and substantial infrastructure investments and
operational expense. Reuters, TIBCO and IBM MQSeries are
competitors in the middleware
market.
|
·
|
CRM
software offers application tools that allow developers to build product
specific interfaces and custom applications. This approach is
not designed to be product neutral and is often dependent on deep
integration with our technology. Siebel is a representative
product in the CRM software
category.
|
·
|
Recently,
there have been several companies that offer capabilities similar to our
Cicero® software in that these companies advertise that they integrate
applications without modifying the underlying code for those applications.
OpenSpan is one company who advertises that they can non-invasively
integrate at the point of contact or on the
desktop.
|
Item
1A.
|
Risk
Factors
|
|
·
|
Cicero®
was originally developed internally by Merrill Lynch and has no track
record of successful sales to organizations within the financial services
industry and may not gain market
acceptance;
|
|
·
|
We
are approaching a different segment of the financial services industry,
the customer contact center, compared to our sales and marketing efforts
in the past and there can be no assurance that we can successfully sell
and market into this industry; and
|
|
·
|
We
have had very limited success because the financial condition of the
Company has caused concern for enterprise customers that would be
dependent on Cicero® for their long-term
needs.
|
|
·
|
make
a special suitability determination for purchasers of our
shares;
|
|
·
|
receive
the purchaser's written consent to the transaction prior to the purchase;
and
|
|
·
|
deliver
to a prospective purchaser of our stock, prior to the first transaction, a
risk disclosure document relating to the penny stock
market.
|
Item
1B.
|
Unresolved
Staff Comments
|
Item
2.
|
Properties
|
Item
3.
|
Legal
Proceedings
|
Item
4.
|
Submission
of Matters to a Vote of Security
Holders
|
Item
5.
|
Market
For Registrant's Common Stock, Related Shareholder Matters and Issuer
Purchases of Equity Securities.
|
2008
|
2007
|
|||||||||||||||
Quarter
|
High
|
Low
|
High
|
Low
|
||||||||||||
First
|
$ | 0.25 | $ | 0.14 | $ | 2.60 | $ | 1.02 | ||||||||
Second
|
$ | 0.19 | $ | 0.14 | $ | 1.13 | $ | 0.16 | ||||||||
Third
|
$ | 0.27 | $ | 0.17 | $ | 0.75 | $ | 0.24 | ||||||||
Fourth
|
$ | 0.20 | $ | 0.09 | $ | 0.29 | $ | 0.15 |
Plan Category
|
Number
of Securities to be issued upon exercise of
outstanding options
|
Weighted-average
exercise price of
outstanding
options
|
Number
of securities remaining available under equity compensation plans
(excluding securities reflected
in the first
column)
|
|||||||||
Equity
compensation plans approved by stockholders
|
26,120 | $ | 79.41 | 1,200 | ||||||||
Equity
compensation plans not approved by stockholders
|
2,685,759 | $ | 0.46 | 1,814,241 | ||||||||
Total
|
2,711,879 | $ | 1.22 | 1,815,441 |
Item
6.
|
Selected
Financial Data.
|
Item
7.
|
Management's Discussion and
Analysis of Financial Condition and Results of
Operations
|
Year Ended December 31,
|
||||||||||||
2008
|
2007
|
2006
|
||||||||||
Revenue:
|
||||||||||||
Software
|
42.5 | % | 27.7 | % | 21.4 | % | ||||||
Maintenance
|
25.3 | % | 16.6 | % | 12.3 | % | ||||||
Services
|
32.2 | % | 55.7 | % | 66.3 | % | ||||||
Total
|
100.0 | % | 100.0 | % | 100.0 | % | ||||||
Cost
of revenue:
|
||||||||||||
Software
|
1.5 | % | 1.0 | % | 0.9 | % | ||||||
Maintenance
|
7.5 | % | 14.6 | % | 21.8 | % | ||||||
Services
|
27.3 | % | 36.2 | % | 56.2 | % | ||||||
Total
|
36.2 | % | 51.8 | % | 78.9 | % | ||||||
Gross
margin
|
63.8 | % | 48.2 | % | 21.1 | % | ||||||
Operating
expenses:
|
||||||||||||
Sales
and marketing
|
27.6 | % | 43.5 | % | 35.6 | % | ||||||
Research
and product development
|
17.8 | % | 31.5 | % | 54.8 | % | ||||||
General
and administrative
|
37.7 | % | 75.0 | % | 124.1 | % | ||||||
(Gain)
on disposal of assets
|
0.0 | % | 0.0 | % | (2.5 | )% | ||||||
Total
|
83.1 | % | 150.0 | % | 212.0 | % | ||||||
Loss
from operations
|
(19.3 | )% | (101.8 | )% | (190.9 | )% | ||||||
Other (expense),
net
|
(4.5 | )% | (7.5 | )% | (117.5 | )% | ||||||
Loss
before taxes
|
(23.8 | )% | (109.3 | )% | (308.4 | )% | ||||||
Income
tax provision (benefit)
|
0.0 | % | 0.0 | % | 0.0 | % | ||||||
Net
loss
|
(23.8 | )% | (109.3 | )% | (308.4 | )% |
2008
|
2007
|
2006
|
||||||||||
United
States
|
100 | % | 100 | % | 100 | % |
For
the year ended December 31,
|
||||||||||||
2008
|
2007
|
2006
|
||||||||||
Total
revenue
|
$ | 3,452 | $ | 1,808 | $ | 972 | ||||||
Total
cost of revenue
|
1,251 | 937 | 767 | |||||||||
Gross
margin
|
2,201 | 871 | 205 | |||||||||
Total
operating expenses
|
2,868 | 2,711 | 2,085 | |||||||||
Segment
loss
|
$ | (667 | ) | $ | (1,840 | ) | $ | (1,880 | ) |
2008
|
2007
|
2006
|
||||||||||
Segment
operating expenses
|
$ | 2,868 | $ | 2,711 | $ | 2,085 | ||||||
(Gain)
on disposal of assets
|
-- | -- | (24 | ) | ||||||||
Total
operating expenses
|
$ | 2,868 | $ | 2,711 | $ | 2,061 |
2008
|
2007
|
2006
|
||||||||||
Total
segment loss
|
$ | (667 | ) | $ | (1,840 | ) | $ | (1,880 | ) | |||
Gain
on disposal of assets
|
-- | -- | 24 | |||||||||
Interest
and other income/(expense), net
|
(156 | ) | (135 | ) | (1,141 | ) | ||||||
Net
loss
|
$ | (823 | ) | $ | (1,975 | ) | $ | (2,997 | ) |
Item
7A.
|
Quantitative
and Qualitative Disclosures about Market
Risk
|
Item
8.
|
Financial
Statements and Supplementary Data
|
Item
9.
|
Changes
in and Disagreements with Accountants on Accounting and Financial
Disclosure
|
Item
9A(T).
|
Controls
and Procedures
|
Item
9B.
|
Other
Information
|
Item
10.
|
Directors,
Executive Officers and Corporate
Governance
|
Name
|
Age
|
Position(s)
|
John
L Steffens
|
67
|
Director
and Chairman
|
John
Broderick
|
59
|
Director
and Chief Executive Officer/Chief Financial Officer
|
Anthony
C. Pizi
|
49
|
Director
|
Mark
Landis
|
67
|
Director
|
Bruce
W. Hasenyager
|
67
|
Director
|
Jay
R. Kingley
|
48
|
Director
|
Charles
B. Porciello
|
73
|
Director
|
Bruce
D. Miller
|
58
|
Director
|
Bruce
A. Percelay
|
53
|
Director
|
John
W. Atherton
|
66
|
Director
|
Don
Peppers
|
58
|
Director
|
Item
11.
|
Executive
Compensation.
|
·
|
Setting
the total compensation of our Chief Executive Officer and evaluating his
performance based on corporate goals and
objectives;
|
·
|
Reviewing
and approving the Chief Executives Officer’s decisions relevant to the
total compensation of the Company’s other executive
officer;
|
·
|
Making
recommendations to the Board of Directors with respect to equity-based
plans in order to allow us to attract and retain qualified personnel;
and
|
·
|
Reviewing
director compensation levels and practices, and recommending, from time to
time, changes in such compensation levels and practices of the Board of
Directors.
|
·
|
Base
salary;
|
·
|
Non-equity
incentive plan compensation;
|
·
|
Long-term
incentive compensation; and
|
·
|
Other
benefits
|
Name
and Principal
Position
|
Fiscal
Year
|
Salary
|
Stock
Awards (1)
|
Option Awards (2)
|
Non-
Equity Incentive Plan
Compensation
(3)
|
All
Other
Compensation
(4)
|
Total
|
|||||||||||||||||||
John
P. Broderick Chief Executive Officer Chief /Financial Officer, Corporate
Secretary
|
2008
|
$ | 175,000 | $ | 36,136 | $ | 91,659 | $ | 25,000 | $ | 6,780 | $ | 334,575 | |||||||||||||
2007
|
$ | 175,000 | $ | 37,396 | $ | 125,838 | -- | $ | 6,862 | $ | 345,096 |
(1)
|
In
August 2007, the Company issued Mr. Broderick a restricted stock award in
the amount of 549,360 shares which will vest to him upon his resignation
or termination or a change of control. The Company used the Black-Scholes
method to value these shares and assumed a life of 10
years.
|
(2)
|
The
Company issued 549,360 options to Mr. Broderick in August 2007. The fair
market on the date of grant was $0.51 each. The options vested one-third
immediately and the balance on each of the next two anniversaries of the
date of grant.
|
(3)
|
Non-equity
incentive plan compensation includes a bonus for certain revenue
transactions for named executive earned during fiscal year ended December
31, 2008.
|
(4)
|
Other
compensation includes the Company’s portion of major medical insurance
premiums and long term disability premiums for named executives during
fiscal year ended December 31,
2008.
|
Option
Awards
|
Stock
Awards
|
||||||||||||||||||
Name
|
Number
of Securities Underlying Unexercised Options # Exercisable
(Vested)
|
Number
of Securities Underlying Unexercised Unearned Options# Unexercisable
(Unvested)
|
Option Exercise price ($)
|
Option Expiration date
|
Number of Shares of Stock That Have Not Vested
(8)
|
Market Value of Shares of Stock That Have Not
Vested
|
|||||||||||||
John
P. Broderick
|
500 | (1) | -- | $ | 400.00 |
05/17/2011
|
|||||||||||||
250 | (2) | -- | $ | 175.00 |
09/25/2011
|
||||||||||||||
909 | (3) | -- | $ | 174.00 |
12/03/2011
|
||||||||||||||
1,000 | (4) | -- | $ | 39.00 |
07/08/2012
|
||||||||||||||
4,950 | (5) | -- | $ | 26.00 |
04/24/2013
|
||||||||||||||
5,000 | (6) | -- | $ | 31.00 |
02/18/2014
|
||||||||||||||
366,240 | (7) | 183,120 | (7) | $ | 0.51 |
08/17/2017
|
|||||||||||||
549,630
|
$ |
85,445
|
(1)
|
These
options were granted on May 17, 2001. This stock option vested and became
exercisable in four equal installments with the first installment vesting
on May 17, 2002.
|
(2)
|
These
options were granted on September 25, 2001. This stock option vested and
became exercisable in four equal annual installments with the first
installment vesting on September 25,
2002.
|
(3)
|
These
options were granted on December 3, 2001. This stock option vested and
became exercisable in three equal annual installments with the first
installment vesting on December 3,
2001.
|
(4)
|
These
options were granted on July 8, 2002. This stock option vested
and became exercisable in three equal annual installments with the first
installment vesting on July 8,
2002.
|
(5)
|
These
options were granted on April 24, 2003. This stock option vested and
became exercisable in three equal annual installments with the first
installment vesting on April 24,
2003.
|
(6)
|
These
options were granted on February 18, 2004. This stock option vested and
became exercisable in three equal annual installments with the first
installment vesting on February 18,
2004.
|
(7)
|
These
options were granted on August 17, 2007. This stock option vests in three
equal installments with the first installment vesting on August 17,
2007.
|
(8)
|
These
are restricted stock granted on August 17, 2007. The shares
will vest to him upon his resignation or termination or a change of
control.
|
Base Salary
|
Restricted Shares Award
|
Deferred Compensation
|
Total Compensation and
Benefits
|
|||||||||||||
John
P. Broderick
|
||||||||||||||||
Death
|
$ | -- | $ | 85,445 | $ | 175,000 | $ | 260,445 | ||||||||
Disability
|
-- | 85,445 | 175,000 | 260,445 | ||||||||||||
Involuntary
termination without cause
|
175,000 | 85,445 | 175,000 | 435,445 | ||||||||||||
Change
in Control
|
175,000 | 85,445 | 175,000 | 435,445 |
Name
|
Fees Earned or Paid in Cash
|
Stock Awards
|
Option Awards
|
Total
|
||||||||||||
John
L. Steffens
|
-- | -- | $ | 2,503 | $ | 2,503 | ||||||||||
Anthony
Pizi
|
-- | -- | $ | 1,564 | $ | 1,564 | ||||||||||
Mark
Landis
|
-- | -- | $ | 1,564 | $ | 1,564 | ||||||||||
Bruce
W. Hasenyager
|
-- | -- | $ | 2,503 | $ | 2,503 | ||||||||||
Jay
R. Kingley
|
-- | -- | $ | 2,503 | $ | 2,503 | ||||||||||
Charles
B. Porciello
|
-- | -- | $ | 2,503 | $ | 2,503 | ||||||||||
Bruce
D. Miller
|
-- | -- | $ | 2,503 | $ | 2,503 | ||||||||||
Bruce
A. Percelay
|
-- | -- | $ | 1,564 | $ | 1,564 | ||||||||||
John
W. Atherton
|
-- | -- | $ | 2,503 | $ | 2,503 | ||||||||||
Don
Peppers
|
-- | -- | $ | 1,564 | $ | 1,564 | ||||||||||
Total
|
-- | -- | $ | 21,274 | $ | 21,274 |
Item
12.
|
Security
Ownership of Certain Beneficial Owners and
Management.
|
Common Stock
|
||||||||
Name of Beneficial Owner
|
No. of Shares
|
Percent of Class
|
||||||
Jonathan
Gallen (1)
|
9,010,472 | (2) | 19.1 | % | ||||
John
L. Steffens (3)
|
5,574,041 | (4) | 11.9 | % | ||||
Mark
and Carolyn P. Landis (5)
|
5,109,863 | (6) | 11.0 | % | ||||
BluePhoenix
Solutions (7)
|
2,801,997 | (8) | 6.0 | % | ||||
Anthony
C. Pizi
|
1,402,634 | (9) | 3.0 | % | ||||
Bruce
Miller
|
2,249,364 | (10) | 4.8 | % | ||||
Bruce
Percelay
|
1,078,486 | (11) | 2.3 | % | ||||
John
P. Broderick
|
931,457 | (12) | 2.0 | % | ||||
John
W. Atherton
|
156,784 | (13) | * | |||||
Bruce
W. Hasenyager
|
41,652 | (14) | * | |||||
Don
Peppers
|
309,050 | (15) | * | |||||
Charles
Porciello
|
88,286 | (16) | * | |||||
Jay
R. Kingley
|
10,000 | (17) | * | |||||
All
current directors and executive officers as a group (11
persons)
|
16,749,317 | (18) | 35.9 | % |
*
|
Represents
less than one percent of the outstanding
shares.
|
1.
|
The
address of Mr. Gallen is 299 Park Avenue New York, New York
10171.
|
2.
|
As
of April 24, 2008, Ahab Partner, L.P. (“Partners”), Ahab International,
Ltd. (“International”), Queequeg Partners, L.P. (“Queequeg”) and Queequeg,
Ltd. (“Limited,” and collectively with Partners, International, and
Queequeg, , the “Funds”) held in aggregate (i) 8,896,136 shares of common
stock and (iii) warrants to acquire 14,336 shares of common stock, which
warrants expire on January 4, 2011. Jonathan Gallen possesses
the sole power to vote and the sole power to direct the disposition of all
securities of the Company held by the Funds. In addition, as of
April 4, 2008, Jonathan Gallen held the power to direct the disposition of
100,000 shares of common stock held in private investment
account. Accordingly, for the purposes of Rule 13d-3 under the
Securities Exchange Act of 1934, as amended, Mr. Gallen may be deemed to
beneficially own 9,010,472 shares of common stock of the
Company. This information is based on a Form 4 filed by Mr.
Gallen on May 21, 2008.
|
3.
|
The
address of John L. Steffens is 65 East 55
th
Street, New York, N.Y. 10022.
|
4.
|
Includes
5,574,041 shares of common stock, 14,832 shares of the Series A-1
Convertible Preferred Stock and 202,617 shares issuable upon the exercise
of warrants and 8,000 shares subject to stock options exercisable within
sixty (60) days. The exercise prices of the warrants are as follows:
14,332 at $10.00 per share and 188,285 at $0.18 per share. The
exercise price of the stock options is $0.51 per
share.
|
5.
|
The
address of Mark and Carolyn P. Landis is 503 Lake Drive, Princeton, New
Jersey 08540.
|
6.
|
Includes
3,748,155 shares of common stock, 1,326,136 shares of the Series A-1
Convertible Preferred Stock, 30,572 shares of common stock issuable upon
the exercise of warrants and 5,000 shares subject to stock options
exercisable within sixty (60) days. The exercise prices of the warrants
and stock options are at $10.00 and $0.51 per share
respectively. Disclaims beneficial ownership of 35,572 shares
because they are anti-dilutive.
|
7.
|
The
address of BluePhoenix Solutions is 8 Maskit Street, PO Box 2062, Herzlia,
Israel 46120.
|
8.
|
Includes
2,801,997 shares of common stock
|
9.
|
Includes
1,274,951 shares of common stock, 111,016 shares of the Series A-1
Convertible Preferred Stock, 11,667 shares of common stock issuable upon
the exercise of warrants and 5,000 shares subject to stock options
exercisable within sixty (60) days. The exercise prices of
warrants and stock options are $10.00 and $0.51 per share of common stock,
respectively.
|
10.
|
Consists
of 1,715,388 shares of common stock, 13,195 shares of common stock
issuable upon the exercise of warrants and 8,000 shares subject to stock
options exercisable within sixty (60) days. The exercise prices
of the warrants and stock options are $10.00 and $0.51 per share of common
stock, respectively. Mr. Miller has sole or shared voting or
dispositive power with respect to the securities held by Delphi Partners,
Ltd., which holds 509,267 shares of common stock and 3,514 shares of
common stock issuable upon the exercise of warrants with an exercise price
at $10.00 per share.
|
11.
|
Consists
of 1,073,486 shares of common stock and 5,000 shares subject to stock
options exercisable within sixty (60) days. The exercise price of stock
options is $0.51 per share of common
stock.
|
12.
|
Includes
3,248 shares of common stock. 378,849 shares subject to stock
options exercisable within sixty (60) days and 549,360 shares of
restricted stock that is awarded upon resignation or termination and
change of control. The exercise prices of stock options range
from $0.51 to $404 per share of common
stock.
|
13.
|
Includes
148,784 shares of common stock, and 100 shares of common stock held in a
self-directed IRA and 8,000 shares subject to stock options exercisable
within sixty (60) days. The exercise price of stock options is
$0.51 per share of common stock.
|
14.
|
Consists
of 32,652 shares of common stock and 9,000 shares subject to stock options
exercisable within sixty (60) days. The exercise prices of
stock options are as follows: 1,000 at $35.00 per share and 8,000 at $0.51
per share of common stock. Disclaims beneficial ownership of
1,000 shares of common stock because they are
anti-dilutive.
|
15.
|
Includes
304,050 shares of common stock and 5,000 shares subject to stock options
exercisable within sixty (60) days. The exercise price of stock options is
$0.51 per share of common stock.
|
16.
|
Consists
of 80,286 shares of common stock and 8,000 shares subject to stock options
exercisable within sixty (60) days. The exercise price of stock options is
$0.51 per share of common stock.
|
17.
|
Consists
of 1,000 shares of common stock and 9,000 shares subject to
stock options exercisable within sixty (60) days. The exercise prices of
stock options are as follows: 1,000 at $34.00 per share and 8,000 at $0.51
per share of common stock.
|
18.
|
Includes
shares issuable upon exercise of options and warrants exercisable within
sixty (60) days as described in Notes 7-14 to our financial
statements.
|
Item
13.
|
Certain
Relationships and Related Transactions, and Director
Independence
|
Item
14.
|
Principal
Accountant Fees and Services
|
Item
15.
|
Exhibits
and Financial Statement Schedules.
|
(A)
|
Financial
Statements
|
(B)
|
Financial
Statement Schedules
|
(C)
|
Exhibits
|
Number
|
Description
|
3.1
|
Certificate
of Incorporation of Level 8 Systems, Inc., a Delaware corporation, as
amended and restated December 29, 2006 (incorporated by reference to
exhibit 3.1 to Level 8’s Form 8-K filed January 17,
2007).
|
3.2
|
Certificate
of Designation relating to Series A1 Convertible Redeemable Preferred
Stock (incorporated by reference to exhibit 3.2 to Level 8’s Form 8-K
filed January 17, 2007).
|
3.3
|
Certificate
of Incorporation of Level 8 Systems, Inc., a Delaware corporation, as
amended August 4, 2003 (incorporated by reference to exhibit 3.1 to Level
8’s Form 10-K filed March 31,
2004).
|
3.4
|
Bylaws
of Level 8 Systems, Inc., a Delaware corporation (incorporated by
reference to exhibit 3.2 to Level 8’s Form 10-K filed April 2,
2002).
|
4.1
|
Registration
Rights Agreement dated July 2006, by and among Level 8 Systems, Inc. and
the Purchasers in the Senior Placement listed on Schedule I thereto
relating to the Security Purchasers Agreement (incorporated by reference
to exhibit 4.1 to Cicero Inc.’s Form 10-K filed March 31,
2008).
|
4.2
|
Registration
Rights Agreement, dated January 2004, by and among Level 8 Systems, Inc.
and the Purchasers in the January 2004 Private Placement listed on
Schedule I thereto relating to the Security Purchasers
Agreement (incorporated by reference to exhibit 4.1 to Level
8’s Form 10-K/A filed April 21,
2004).
|
4.3
|
Registration
Rights Agreement dated as of March 19, 2003 by and among Level 8 Systems,
Inc. and the Purchasers listed on Schedule I thereto relating to the
Series D Convertible Redeemable Preferred Stock (incorporated by reference
to exhibit 4.1 to Level 8’s Form 8-K, filed March 31,
2003).
|
4.4
|
Registration
Rights Agreement dated as of October 15, 2003 by and among Level 8
Systems, Inc. and the Purchasers in the October Private Placement listed
on schedule I thereto (incorporated by reference to exhibit 4.2 to Level
8’s Form 10-K, filed March 31,
2004).
|
4.5
|
Registration
Rights Agreement, dated as of January 16, 2002, by and among Level 8
Systems, Inc. and the Purchasers in the January Private Placement listed
on Schedule I thereto (incorporated by reference to exhibit 4.1 to Level
8's Report on Form 8-K, filed January 25,
2002).
|
4.6
|
Registration
Rights Agreement, dated as of January 3, 2002, between Level 8 Systems,
Inc. and MLBC, Inc. (incorporated by reference to exhibit 4.1 to Level 8's
Report on Form 8-K, filed January 11,
2002).
|
4.7
|
Registration
Rights Agreement, dated as of August 29, 2002, entered into by and between
Level 8 Systems, Inc. and the holders of Series A2/A3 Preferred Stock and
Series B2/B3 Preferred Stock (incorporated by reference to exhibit 10.4 to
Level 8’s Form 8-K filed August 30,
2002).
|
4.7A
|
First
Amendment to Registration Rights Agreement, dated as of October 25, 2002,
entered into by and between Level 8 Systems, Inc. and the holders of
Series A2/A3 Preferred Stock and Series B2/B3 Preferred Stock
(incorporated by reference to exhibit 10.4 to Level 8’s Form 10-Q filed
November 15, 2002).
|
4.8
|
Registration
Rights Agreement, dated as of June 13, 1995, between Level 8 Systems, Inc.
and Liraz Systems Ltd. (incorporated by reference to exhibit 10.24 to
Across Data Systems, Inc.'s (Level 8's predecessor) Registration Statement
on Form S-1, filed May 12, 1995, File No.
33-92230).
|
4.8A
|
First
Amendment to Registration Rights Agreement, dated as of August 8, 2001, to
the Registration Rights Agreement dated as of June 13, 1995, by and
between Across Data Systems, Inc. (Level 8's predecessor) and Liraz
Systems Ltd. (incorporated by reference to exhibit 4.1 to Level 8's Report
on Form 8-K, filed August 14,
2001).
|
4.9
|
Registration
Rights Agreement, dated as of August 14, 2002, entered into by and between
Level 8 Systems, Inc. and the investors in Series C Preferred Stock
(incorporated by reference to exhibit 4.1 to Level 8’s Form 8-K filed
August 27, 2002).
|
4.10
|
Form
of Registration Rights Agreement, dated January 2004, by and among Level 8
Systems, Inc. and the Purchasers of Convertible Promissory Note
(incorporated by reference to exhibit 4.2 to Level 8's Report on Form
10-Q, filed May 12, 2004).
|
4.11
|
Form
of Warrant issued to the Purchasers in the Series D Preferred Stock
transaction dated as of March 19, 2003 (incorporated by reference to
exhibit 4.2 to Level 8's Form 8-K, filed March 31,
2003).
|
4.11A
|
Form
of Warrant issued to the Purchasers in the Series D Preferred Stock
transaction dated as of March 19, 2003 (incorporated by reference to
exhibit 4.2 to Level 8's Form 8-K, filed March 31,
2003).
|
4.12
|
Form
of Stock Purchase Warrant issued to Purchasers in the October 2003 Private
Placement (incorporated by reference to exhibit 4.9 to Level 8’s Form
10-K, filed March31, 2004).
|
4.13
|
Form
of Series A3 Stock Purchase Warrant (incorporated by reference to exhibit
10.2 of Level 8’s Form 10-Q filed November 15,
2002).
|
4.14
|
Form
of Series B3 Stock Purchase Warrant (incorporated by reference to exhibit
10.3 of Level 8’s Form 10-Q filed November 15,
2002).
|
4.15
|
Form
of Series C Stock Purchase Warrant (incorporated by reference to exhibit
10.2 to Level 8’s Form 8-K filed August 27,
2002)
|
4.16
|
Form
of Long term Promissory Note Stock Purchase Warrant (incorporated by
reference to exhibit 4.19 to Cicero Inc.’s Form 10-K filed March 31,
2008).
|
Form
of Long term Promissory Note Stock Purchase Warrant (filed
herewith).
|
10.1
|
Securities
Purchase Agreement for Consortium IV (incorporated by reference to exhibit
10.1 to Cicero Inc.’s Form 10-K/A filed July 11,
2007).
|
10.2
|
Amended
PCA Shell License Agreement, dated as of January 3, 2002, between Level 8
Systems, Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated
(incorporated by reference to exhibit 10.2 to Level 8's Form 8-K, filed
January 11, 2002).
|
10.3A
|
PCA
Shell License Agreement between Level 8 Systems, Inc. and Merrill Lynch,
Pierce, Fenner & Smith Incorporated (incorporated by reference to
exhibit 10.2 to Level 8’s Report on Form 8-K, filed September 11,
2000).
|
10.3B
|
OEM
License Agreement between Cicero Inc. and Merrill Lynch, Pierce, Fenner
& Smith Incorporated (incorporated by reference to exhibit 10.12A to
Cicero Inc.’s Form 10-K filed March 31,
2008).
|
10.3C
|
Software
Support and Maintenance Schedule between Cicero Inc. and Merrill Lynch,
Pierce, Fenner & Smith Incorporated (incorporated by reference to
exhibit 10.12A to Cicero Inc.’s Form 10-K filed March 31,
2008).
|
Employment
Agreement between John P. Broderick and the Company effective January 1,
2008 (filed herewith).*
|
10.5
|
Lease
Agreement for Cary, N.C. offices, dated November 7, 2003, between Level 8
Systems, Inc. and Regency Park Corporation (incorporated by reference to
exhibit 10.17 to Level 8’s Form 10-K, filed March 31,
2004).
|
10.6
|
Level
8 Systems Inc. 1997 Stock Option Plan, as Amended and Restated
(incorporated by reference to exhibit 10.2 to Level 8’s Registration
Statement of Form S-1/A, filed September 22, 2000, File No.
333-44588).*
|
10.7A
|
Fifth
Amendment to Level 8 Systems Inc. 1997 Stock Option Plan (incorporated by
reference to exhibit 10.9A to Level 8’s Form 10-K filed April 2,
2002).*
|
10.8B
|
Seventh
Amendment to Level 8 Systems Inc. 1997 Stock Option Plan (incorporated by
reference to exhibit 10.14 B to Level 8’s Form 10-K, filed March 31,
2004).*
|
10.9
|
Lease
Agreement for Cary, N.C. offices, dated August 16
,
2007, between Cicero Inc. and Regency Park Corporation
(incorporated by reference to exhibit 10.21 to Cicero Inc.’s Form 10-K
filed March 31, 2008).
|
10.10
|
Cicero
Inc. 2007 Employee Stock Option Plan (incorporated by reference to exhibit
10.22 to Cicero Inc.’s Form 10-K filed March 31,
2008).
|
10.11
|
Agreement
and Promissory Note of Cicero Inc,, dated October 30, 2007 among Cicero
Inc. and BluePhoenix Solutions Ltd. (incorporated by reference to exhibit
10.23 to Cicero Inc.’s Form 10-K filed March 31,
2008).
|
10.12
|
Promissory
Note of Cicero Inc., dated October 29, 2007 among Cicero Inc. and John L.
Steffens (incorporated by reference to exhibit 10.24 to Cicero Inc.’s Form
10-K filed March 31, 2008).
|
10.13
|
Securities
Purchase Agreement, dated as of February 26, 2007, by and among Cicero
Inc. and the Purchasers in the February Private Placement (incorporated by
reference to exhibit 10.25 to Cicero Inc.’s Form 10-K filed March 31,
2008).
|
10.14
|
Securities
Purchase Agreement, dated as of August 15, 2007, by and among Cicero Inc.
and the Purchasers in the August Private Placement (incorporated by
reference to exhibit 10.26 to Cicero Inc.’s Form 10-K filed March 31,
2008).
|
Revolving
Loan Agreement dated November 3, 2008 among Cicero Inc. and Barbara Sivan
(filed herewith).
|
Employment
Agreement between John P. Broderick and the Company effective January 1,
2009 (filed herewith).*
|
Form
of Long Term Promissory Note dated March 31, 2009 (filed
herewith).
|
14.1
|
Code
of Ethics (incorporated by reference to exhibit 14.1 to Level 8’s Form
10-K/A, filed March 31, 2004).
|
List
of subsidiaries of the Company (filed
herewith).
|
Consent
of Margolis & Company P.C. (filed
herewith).
|
Certification
of Chief Executive pursuant to Rule 13a-14(a) (filed
herewith).
|
Certification
of Chief Financial Officer pursuant to Rule 13a-14(a) (filed
herewith).
|
Certification
of John P. Broderick pursuant to 18 USC § 1350, as adopted pursuant to
§906 of the Sarbanes-Oxley Act of 2002 (filed
herewith).
|
*
|
Management
contract or compensatory agreement.
|
CICERO
INC.
|
|
By:
/s/ John P.
Broderick
|
|
John
P. Broderick
|
|
Chief
Executive Officer
|
|
Date:
March 31, 2009
|
Signature
|
Title
|
Date
|
/s/ John
L. Steffens
John
L. Steffens
|
Chairman
of the Board
|
March
31, 2009
|
/s/ John
P. Broderick
John
P. Broderick
|
Chief
Executive Officer/Chief Financial Officer
(Principal
Executive Officer)
|
March
31, 2009
|
/s/ Mark
Landis
Mark
Landis
|
Director
|
March
31, 2009
|
/s/ Anthony
C. Pizi
Anthony
C. Pizi
|
Director
|
March
31, 2009
|
/s/ Bruce
Hasenyager
Bruce
Hasenyager
|
Director
|
March
31, 2009
|
/s/ Jay
Kingley
Jay
Kingley
|
Director
|
March
31, 2009
|
/s/ Bruce D.
Miller
Bruce
D. Miller
|
Director
|
March
31, 2009
|
/s/ Charles
Porciello
Charles
Porciello
|
Director
|
March
31, 2009
|
/s/ Bruce
Percelay
Bruce
Percelay
|
Director
|
March
31, 2009
|
/s/ John W.
Atherton
John
W. Atherton
|
Director
|
March
31, 2009
|
/s/ Don
Peppers
Don
Peppers
|
Director
|
March
31,
2009
|
/s/
Margolis & Company P.C.
|
|
Certified
Public Accountants
|
December 31, 2008
|
December 31, 2007
|
|||||||
ASSETS
|
||||||||
Current
assets:
|
||||||||
Cash
and cash equivalents
|
$ | 63 | $ | 250 | ||||
Assets
of operations to be abandoned
|
71 | 79 | ||||||
Trade
accounts receivable, net
|
759 | 692 | ||||||
Prepaid
expenses and other current assets
|
255 | 208 | ||||||
Total
current assets
|
1,148 | 1,229 | ||||||
Property
and equipment, net
|
46 | 22 | ||||||
Total
assets
|
$ | 1,194 | $ | 1,251 | ||||
LIABILITIES
AND STOCKHOLDERS' DEFICIT
|
||||||||
Current
liabilities:
|
||||||||
Short-term
debt
(Note
5)
|
$ | 1,192 | $ | 1,235 | ||||
Accounts
payable
|
2,258 | 2,489 | ||||||
Accrued
expenses:
|
||||||||
Salaries,
wages, and related items
|
1,051 | 1,002 | ||||||
Other
|
2,027 | 2,072 | ||||||
Liabilities
of operations to be abandoned
|
429 | 455 | ||||||
Deferred
revenue
|
348 | 108 | ||||||
Total
current liabilities
|
7,305 | 7,361 | ||||||
Long-term
debt
(Note
6)
|
971 | 1,323 | ||||||
Total
liabilities
|
8,276 | 8,684 | ||||||
Commitments
and contingencies (Notes 14 and 15)
|
||||||||
Stockholders'
deficit:
|
||||||||
Convertible
preferred stock, $0.001 par value, 10,000,000 shares
authorized
|
||||||||
Series
A-1 – 1,543.6 shares issued and outstanding at December 31, 2008, $500 per
share liquidation preference (aggregate liquidation value of $772) and
1,603.6 shares issued and outstanding at December 31, 2007, $500 per share
liquidation preference (aggregate liquidation value of
$802)
|
-- | -- | ||||||
Common
stock, $0.001 par value, 215,000,000 shares authorized at December 31,
2008 and 2007, respectively; 46,642,396 and 43,805,508 issued and
outstanding at December 31, 2008 and 2007, respectively (Note
2)
|
47 | 44 | ||||||
Additional
paid-in-capital
|
230,018 | 228,858 | ||||||
Accumulated
deficit
|
(237,143 | ) | (236,320 | ) | ||||
Accumulated
other comprehensive loss
|
(4 | ) | (15 | ) | ||||
Total
stockholders' deficit
|
(7,082 | ) | (7,433 | ) | ||||
Total
liabilities and stockholders' deficit
|
$ | 1,194 | $ | 1,251 |
Years
Ended December 31,
|
||||||||||||
2008
|
2007
|
2006
|
||||||||||
Revenue:
|
||||||||||||
Software
|
$ | 1,467 | $ | 501 | $ | 208 | ||||||
Maintenance
|
873 | 300 | 120 | |||||||||
Services
|
1,112 | 1,007 | 644 | |||||||||
Total
operating revenue
|
3,452 | 1,808 | 972 | |||||||||
Cost
of revenue:
|
||||||||||||
Software
|
50 | 19 | 9 | |||||||||
Maintenance
|
260 | 264 | 212 | |||||||||
Services
|
941 | 654 | 546 | |||||||||
Total
cost of revenue
|
1,251 | 937 | 767 | |||||||||
Gross
margin
|
2,201 | 871 | 205 | |||||||||
Operating
expenses:
|
||||||||||||
Sales
and marketing
|
952 | 786 | 346 | |||||||||
Research
and product development
|
615 | 569 | 533 | |||||||||
General
and administrative
|
1,301 | 1,356 | 1,206 | |||||||||
(Gain)
on disposal of assets
|
- | - | (24 | ) | ||||||||
Total
operating expenses
|
2,868 | 2,711 | 2,061 | |||||||||
Loss
from operations
|
(667 | ) | (1,840 | ) | (1,856 | ) | ||||||
Other
income (charges):
|
||||||||||||
Interest
expense
|
(223 | ) | (257 | ) | (853 | ) | ||||||
Other
|
67 | 122 | (288 | ) | ||||||||
(156 | ) | (135 | ) | (1,141 | ) | |||||||
Net
loss
|
$ | (823 | ) | $ | (1,975 | ) | $ | (2,997 | ) | |||
Accretion
of preferred stock and deemed dividends
|
- | - | 5,633 | |||||||||
Net
loss applicable to common stockholders
|
$ | (823 | ) | $ | (1,975 | ) | $ | (8,630 | ) | |||
Loss
per share:
|
||||||||||||
Basic
loss per share
|
$ | (0.02 | ) | $ | (0.05 | ) | $ | (0.25 | ) | |||
Diluted
loss per share
|
$ | (0.02 | ) | $ | (0.05 | ) | $ | (0.25 | ) | |||
Average
shares outstanding:
|
||||||||||||
Basic
|
46,642 | 36,771 | 35,182 | |||||||||
Potential
dilutive common shares
|
12 | -- | -- | |||||||||
Diluted
|
46,654 | 36,771 | 35,182 |
Common
Stock
|
Preferred
Stock
|
Additional Paid-in
|
Accumulated
|
Accumulated Other
Comprehensive
|
||||||||||||||||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
Capital
|
(Deficit)
|
Income (Loss)
|
Total
|
|||||||||||||||||||||||||
Balance
at December 31, 2005
|
48,017 | $ | 48 | 33 | $ | -- | $ | 210,594 | $ | (225,715 | ) | $ | (3 | ) | $ | (15,076 | ) | |||||||||||||||
Reverse
stock split 100:1
|
(47,536 | ) | ( 48 | ) | (33 | ) | 48 | -- | ||||||||||||||||||||||||
Balance
at December 31, 2005 as adjusted for stock split
|
481 | -- | -- | -- | 210,642 | (225,715 | ) | (3 | ) | (15,076 | ) | |||||||||||||||||||||
Shares
issued from conversion of senior reorganization debt
|
3,438 | 3 | 1,705 | 1,708 | ||||||||||||||||||||||||||||
Shares
issued from conversion of convertible bridge notes
|
30,508 | 32 | 3,877 | 3,909 | ||||||||||||||||||||||||||||
Shares
issued for bank guarantee
|
96 | 312 | 312 | |||||||||||||||||||||||||||||
Shares
issued from short term debt conversion
|
224 | 190 | 190 | |||||||||||||||||||||||||||||
Shares
issued from conversion of convertible promissory notes
|
2 | 992 | 992 | |||||||||||||||||||||||||||||
Conversion
of senior convertible redeemable preferred stock
|
1,061 | 1,061 | ||||||||||||||||||||||||||||||
Conversion
of warrants
|
99 | 1,086 | 1,086 | |||||||||||||||||||||||||||||
Shares
issued for interest conversion
|
211 | 629 | 629 | |||||||||||||||||||||||||||||
Shares
issued as compensation
|
125 | 280 | 280 | |||||||||||||||||||||||||||||
Accretion
of preferred stock
|
529 | (529 | ) | -- | ||||||||||||||||||||||||||||
Deemed
dividend
|
5,104 | (5,104 | ) | -- | ||||||||||||||||||||||||||||
Foreign
currency translation adjustment
|
(6 | ) | (6 | ) | ||||||||||||||||||||||||||||
Net
loss
|
(2,997 | ) | (2,997 | ) | ||||||||||||||||||||||||||||
Balance
at December 31, 2006
|
35,182 | 35 | 2 | -- | 226,407 | (234,345 | ) | (9 | ) | (7,912 | ) | |||||||||||||||||||||
Shares
issued for private placement
|
5,892 | 6 | 1,034 | 1,040 | ||||||||||||||||||||||||||||
Shares
issued for litigation settlement
|
25 | 50 | 50 | |||||||||||||||||||||||||||||
Conversion
of preferred shares to common
|
160 | -- | ||||||||||||||||||||||||||||||
Options
issued as compensation
|
650 | 650 | ||||||||||||||||||||||||||||||
Restricted
shares issued as compensation
|
36 | 36 | ||||||||||||||||||||||||||||||
Warrant
issued
|
34 | 34 | ||||||||||||||||||||||||||||||
Shares
issued with refinancing of debt
|
2,546 | 3 | 647 | 650 | ||||||||||||||||||||||||||||
Foreign
currency translation adjustment
|
(6 | ) | (6 | ) | ||||||||||||||||||||||||||||
Net
loss
|
(1,975 | ) | (1,975 | ) | ||||||||||||||||||||||||||||
Balance
at December 31, 2007
|
43,805 | 44 | 2 | -- | 228,858 | (236,320 | ) | (15 | ) | (7,433 | ) | |||||||||||||||||||||
Shares
issued for loan refinancing
|
1,425 | 1 | 362 | 363 | ||||||||||||||||||||||||||||
Conversion
of preferred shares to common
|
60 | -- | ||||||||||||||||||||||||||||||
Shares
issued for account payable refinancing
|
623 | 1 | 159 | 160 | ||||||||||||||||||||||||||||
Shares
issued for loan conversion
|
392 | 1 | 100 | 101 | ||||||||||||||||||||||||||||
Shares
issued for loan conversion and S1 delay
|
256 | 65 | 65 | |||||||||||||||||||||||||||||
Shares
issued for account payable conversion
|
81 | 21 | 21 | |||||||||||||||||||||||||||||
Options
issued as compensation
|
417 | 417 | ||||||||||||||||||||||||||||||
Restricted
shares issued as compensation
|
36 | 36 | ||||||||||||||||||||||||||||||
Foreign
currency translation adjustment
|
11 | 11 | ||||||||||||||||||||||||||||||
Net
loss
|
(823 | ) | (823 | ) | ||||||||||||||||||||||||||||
Balance
at December 31, 2008
|
46,642 | $ | 47 | 2 | $ | -- | $ | 230,018 | $ | (237,143 | ) | $ | (4 | ) | $ | (7,082 | ) |
Years
Ended December 31,
|
||||||||||||
2008
|
2007
|
2006
|
||||||||||
Net
loss
|
$ | (823 | ) | $ | (1,975 | ) | $ | (2,997 | ) | |||
Other
comprehensive income (loss), net of tax:
|
||||||||||||
Foreign
currency translation adjustment
|
11 | (6 | ) | (6 | ) | |||||||
Comprehensive
loss
|
$ | (812 | ) | $ | (1,981 | ) | $ | (3,003 | ) |
Years
Ended December 31,
|
||||||||||||
2008
|
2007
|
2006
|
||||||||||
Cash
flows from operating activities:
|
||||||||||||
Net
loss
|
$ | (823 | ) | $ | (1,975 | ) | $ | (2,997 | ) | |||
Adjustments
to reconcile net loss to net cash (used in) operating
activities:
|
||||||||||||
Depreciation
and amortization
|
17 | 10 | 12 | |||||||||
Stock
compensation expense
|
453 | 720 | 614 | |||||||||
Issuance
of stock
|
15 | -- | -- | |||||||||
Provision
(credit) for doubtful accounts
|
(100 | ) | 50 | 60 | ||||||||
Gain on
disposal of assets
|
-- | -- | 24 | |||||||||
Changes
in assets and liabilities, net of assets acquired and liabilities
assumed:
|
||||||||||||
Trade
accounts receivable and related party receivables
|
33 | (622 | ) | (212 | ) | |||||||
Assets
and liabilities of operations to be abandoned
|
(18 | ) | 21 | (27 | ) | |||||||
Prepaid
expenses and other assets
|
(47 | ) | (136 | ) | 31 | |||||||
Accounts
payable and accrued expenses
|
178 | 478 | 311 | |||||||||
Deferred
revenue
|
240 | 70 | (40 | ) | ||||||||
Net
cash (used in) operating activities
|
(52 | ) | (1,384 | ) | (2,224 | ) | ||||||
Cash
flows from investing activities:
|
||||||||||||
Purchases
of property and equipment
|
(41 | ) | (17 | ) | (17 | ) | ||||||
Net
cash (used in) investing activities
|
(41 | ) | (17 | ) | (17 | ) | ||||||
Cash
flows from financing activities:
|
||||||||||||
Proceeds
from issuance of common shares, net of issuance costs
|
-- | 1,040 | 380 | |||||||||
Borrowings
under credit facility, term loans and notes payable
|
1,395 | 984 | 2,148 | |||||||||
Repayments
of term loans, credit facility and notes payable
|
(1,500 | ) | (677 | ) | -- | |||||||
Net
cash provided by (used in) financing activities
|
(105 | ) | 1,347 | 2,528 | ||||||||
Effect
of exchange rate changes on cash
|
11 | (6 | ) | (6 | ) | |||||||
Net
increase (decrease) in cash and cash equivalents
|
(187 | ) | (60 | ) | 281 | |||||||
Cash
and cash equivalents at beginning of year
|
250 | 310 | 29 | |||||||||
Cash
and cash equivalents at end of year
|
$ | 63 | $ | 250 | $ | 310 | ||||||
SUPPLEMENTAL
DISCLOSURES OF CASH FLOW INFORMATION
|
||||||||||||
Cash
paid during the year for:
|
||||||||||||
Income
taxes
|
$ | 1 | $ | 5 | $ | 20 | ||||||
Interest
|
$ | 227 | $ | 264 | $ | 865 |
NOTE
1.
|
SUMMARY
OF OPERATIONS, SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING
PRONOUNCEMENTS
|
2008
|
2007
|
2006
|
||||||||||
Stock
options
|
2,711,879 | 2,529,025 | 45,315 | |||||||||
Warrants
|
390,400 | 445,387 | 323,623 | |||||||||
Preferred
stock
|
1,543,618 | 1,603,618 | 1,763,478 | |||||||||
4,645,897 | 4,578,030 | 2,132,416 |
2007
|
2007
|
2006
|
||||||||||
Expected
life (in years)
|
10.0
years
|
10.0
years
|
3.6
years
|
|||||||||
Expected
volatility
|
106%-151 | % | 166 | % | 140 | % | ||||||
Risk
free interest rate
|
0.15%-4.24 | % | 5.25 | % | 4.93 | % | ||||||
Expected
dividend yield
|
0 | % | 0 | % | 0 | % |
NOTE
2.
|
RECAPITALIZATION
|
NOTE
3.
|
ACCOUNTS
RECEIVABLE
|
2008
|
2007
|
|||||||
Current
trade accounts receivable
|
$ | 759 | $ | 792 | ||||
Less:
allowance for doubtful accounts
|
-- | 100 | ||||||
$ | 759 | $ | 692 |
NOTE
4.
|
PROPERTY
AND EQUIPMENT
|
2008
|
2007
|
|||||||
Computer
equipment
|
$ | 283 | $ | 263 | ||||
Furniture
and fixtures
|
19 | 8 | ||||||
Office
equipment
|
164 | 154 | ||||||
466 | 425 | |||||||
Less:
accumulated depreciation and amortization
|
(420 | ) | (403 | ) | ||||
$ | 46 | $ | 22 |
NOTE
5.
|
SHORT-TERM
DEBT
|
2008
|
2007
|
|||||||
Term
loan (a)
|
$ | 100 | $ | -- | ||||
Note
payable related party (b)
|
94 | 49 | ||||||
Notes
payable (c)
|
998 | 1,186 | ||||||
$ | 1,192 | $ | 1,235 |
(a)
|
At
December 31, 2008, the Company was indebted to BluePhoenix Solutions for
the current portion of the related long term debt of $100,000. (See Note
6)
|
(b)
|
In
June 2008, the Company entered into a short term note payable with John L.
(Launny) Steffens, the Chairman of the Board of Directors, for various
working capital needs. The Note bears interest at 10% per year and is
unsecured. At December 31, 2008, the Company was indebted to Mr. Steffens
in the amount of $45,000.
|
(c)
|
The
Company does not have a revolving credit facility and from time to time
has issued a series of short term promissory notes with private lenders,
which provide for short term borrowings, both secured by accounts
receivable and unsecured. In addition, the Company has settled
certain litigation and agreed to issue a series of promissory notes to
support its obligations in the aggregate principal amount of $88,000. The
notes bear interest between 10% and 36% per
annum.
|
NOTE
6.
|
LONG-TERM
DEBT
|
2008
|
2007
|
|||||||
Term
loan (a)
|
$ | 671 | $ | 1,021 | ||||
Note
payable, related party (b)
|
300 | 300 | ||||||
Other
long-term debt
|
-- | 2 | ||||||
$ | 971 | $ | 1,323 |
(a)
|
In
October 2007, the Company, in conjunction with BluePhoenix Solutions,
retired the note payable to Bank Hapoalim and entered into a new note with
Blue Phoenix Solutions in the principal amount of $1,021,000 with interest
at Libor plus 1% (approximately 4.17% at December 31, 2008) maturing in
December 2011. Interest is payable quarterly. At December 31, 2008, the
Company was indebted to BluePhoenix Solutions in the amount of $771,000 of
which $100,000 is classified as short term
debt.
|
(b)
|
In
October 2007, the Company entered into a long-term note with John L.
(Launny) Steffens, the Chairman on the Board of Directors, as part of the
restructuring of the Note payable to Bank Hapoalim. The Note
bears interest of 3% and matures in October 2009. At December
31, 2008, the Company was indebted to Mr. Steffens in the amount of
$300,000. In March 2009, the Company and Mr. Steffens agreed to
extend the maturity on the above Note until October
2010.
|
Year
|
||||
2010
|
$ | 300 | ||
2011
|
$ | 671 | ||
NOTE
7.
|
INCOME
TAXES
|
2008
|
2007
|
2006
|
||||||||||
Expected
income tax benefit at statutory rate (34%)
|
$ | (280 | ) | $ | (672 | ) | $ | (1,019 | ) | |||
State
taxes, net of federal tax benefit.
|
(49 | ) | (118 | ) | (180 | ) | ||||||
Effect
of change in valuation allowance
|
326 | 788 | 1,073 | |||||||||
Non-deductible
expenses
|
3 | 2 | 126 | |||||||||
Total
|
$ | -- | $ | -- | $ | -- |
2008
|
2007
|
|||||||
Current
assets:
|
||||||||
Allowance
for doubtful accounts
|
$ | -- | $ | 44 | ||||
Accrued
expenses, non-tax deductible
|
371 | 222 | ||||||
Deferred
revenue
|
139 | 44 | ||||||
Noncurrent
assets:
|
||||||||
Stock
compensation expense
|
296 | 287 | ||||||
Loss
carryforwards
|
93,217 | 92,337 | ||||||
Depreciation
and amortization
|
4,356 | 5,119 | ||||||
98,379 | 98,053 | |||||||
Less:
valuation allowance
|
(98,379 | ) | (98,053 | ) | ||||
$ | -- | $ | -- |
NOTE
8.
|
STOCKHOLDERS’
EQUITY
|
Plan
Activity
|
Option Price
Per Share
|
Weighted Average
Exercise Price
|
||||||||||
Balance
at December 31, 2005
|
59,010 | 12.00-3,931.00 | 124.00 | |||||||||
Forfeited
|
(13,695 | ) | 22.00-3,931.00 | 137.14 | ||||||||
Balance
at December 31, 2006
|
45,315 | 12.00-3,931.00 | 120.61 | |||||||||
Granted
|
2,756,173 | 0.51 | 0.51 | |||||||||
Forfeited
|
(270,413 | ) | 0.51-612.50 | 12.21 | ||||||||
Expired
|
(2,050 | ) | 1,473.00 | 1,473.00 | ||||||||
Balance
at December 31, 2007
|
2,529,025 | 0.51-3,931.00 | 1.35 | |||||||||
Granted
|
475,000 | 0.10-0.25 | 0.19 | |||||||||
Forfeited
|
(292,146 | ) | 0.17-1,881.25 | 0.74 | ||||||||
Balance
at December 31, 2008
|
2,711,879 | 0.10-3,931.25 | 1.22 |
EXERCISE PRICE
|
NUMBER
OUTSTANDING
|
REMAINING
CONTRACTUAL LIFE FOR OPTIONS
OUTSTANDING
|
NUMBER
EXERCISABLE
|
WEIGHTED
AVERAGE EXERCISE
PRICE
|
||||||||||||
$ 0.10-0.50
|
451,666 | 9.4 | 149,999 | $ | 0.20 | |||||||||||
0.51-0.51
|
2,234,093 | 8.6 | 1,512,068 | 0.51 | ||||||||||||
0.52-393.12
|
24,545 | 4.4 | 24,545 | 41.77 | ||||||||||||
393.13-786.25
|
1,350 | 2.2 | 1,350 | 532.20 | ||||||||||||
786.26-3,931.25
|
225 | 1.1 | 225 | 1,467.57 | ||||||||||||
2,711,879 | 8.7 | 1,688,187 | $ | 1.70 |
Expected
Life in
Years
|
Expected
Volatility
|
Risk
Free Interest
Rate
|
Expected
Dividend
|
Fair
Value of Common
Stock
|
|||||||||||||
Preferred
Series D-1 Warrants
|
5 | 117 | % | 3 | % |
None
|
$ | 7.00 | |||||||||
Preferred
Series D-2 Warrants
|
5 | 102 | % | 3 | % |
None
|
$ | 20.00 | |||||||||
Early
Adopter Warrants
|
4 | 104 | % | 4 | % |
None
|
$ | 1.50 | |||||||||
Long
Term Promissory Note Warrants
|
10 | 168 | % | 5.25 | % |
None
|
$ | 0.18 |
NOTE
9.
|
EMPLOYEE
BENEFIT PLANS
|
NOTE
10.
|
SIGNIFICANT
CUSTOMERS AND CONCENTRATION OF CREDIT
RISK
|
NOTE
11.
|
FOREIGN
CURRENCIES
|
NOTE
12.
|
SEGMENT
INFORMATION AND GEOGRAPHIC
INFORMATION
|
For
the year ended December 31,
|
||||||||||||
2008
|
2007
|
2006
|
||||||||||
Total
revenue
|
$ | 3,452 | $ | 1,808 | $ | 972 | ||||||
Total
cost of revenue
|
1,251 | 937 | 767 | |||||||||
Gross
margin
|
2,201 | 871 | 205 | |||||||||
Total
operating expenses
|
2,868 | 2,711 | 2,085 | |||||||||
Segment
loss
|
$ | (667 | ) | $ | (1,840 | ) | $ | (1,880 | ) |
2008
|
2007
|
2006
|
||||||||||
Segment
operating expenses
|
$ | 2,868 | $ | 2,711 | $ | 2,085 | ||||||
(Gain)
on disposal of assets
|
-- | -- | (24 | ) | ||||||||
Total
operating expenses
|
$ | 2,868 | $ | 2,711 | $ | 2,061 |
2008
|
2007
|
2006
|
||||||||||
Total
segment profitability (loss)
|
$ | (667 | ) | $ | (1,840 | ) | $ | (1,880 | ) | |||
Gain
on disposal of assets
|
-- | -- | 24 | |||||||||
Interest
and other income/(expense), net
|
(156 | ) | (135 | ) | (1,141 | ) | ||||||
Net
loss
|
$ | (823 | ) | $ | (1,975 | ) | $ | (2,997 | ) |
2008
|
2007
|
2006
|
||||||||||
USA
|
$ | 3,452 | $ | 1,808 | $ | 972 |
NOTE
13.
|
RELATED
PARTY INFORMATION
|
NOTE
14.
|
LEASE
COMMITMENTS
|
Lease
Commitments
|
||||
2009
|
$ | 106 | ||
2010
|
101 | |||
$ | 207 |
NOTE
15.
|
CONTINGENCIES
|
NOTE
16.
|
SELECTED
QUARTERLY FINANCIAL DATA
(UNAUDITED)
|
First
Quarter
|
Second
Quarter
|
Third
Quarter
|
Fourth
Quarter
|
|||||||||||||
(In
thousands, except per share data)
|
||||||||||||||||
2008:
|
||||||||||||||||
Net
revenues
|
$ | 470 | $ | 1,427 | $ | 578 | $ | 977 | ||||||||
Gross
margin
|
230 | 1,153 | 264 | 554 | ||||||||||||
Net
income/(loss)
|
(485 | ) | 430 | (553 | ) | (215 | ) | |||||||||
Net
income/(loss) share –basic and diluted attributed to common
stockholders
|
$ | (0.01 | ) | $ | 0.01 | $ | (0.01 | ) | -- | |||||||
2007:
|
||||||||||||||||
Net
revenues
|
$ | 232 | $ | 316 | $ | 387 | $ | 873 | ||||||||
Gross
margin
|
65 | 160 | 82 | 564 | ||||||||||||
Net
loss
|
(529 | ) | (452 | ) | (966 | ) | (28 | ) | ||||||||
Net
loss/share –basic and diluted attributed to common
stockholders
|
$ | (0.01 | ) | $ | (0.01 | ) | $ | (0.02 | ) | -- |
NOTE
17.
|
SUBSEQUENT
EVENTS
|
X
|
=
|
Y x
(A-B)/A
|
|
where
|
X
|
=
|
the
number of Warrant Shares to be issued to the Holder;
|
Y
|
=
|
the
number of Warrant Shares with respect to which this Warrant is being
exercised;
|
|
A
|
=
|
the
Market Price of a share of Common Stock as of the Date of Exercise;
and
|
|
B
|
=
|
the
Exercise Price.
|
Cicero,
Inc.
|
||
By:
|
||
John
Broderick
|
||
Chief
Executive Officer
|
||
Holder
|
||
By:
|
||
Name:
|
||
Title:
|
|
TO:
|
Cicero,
Inc.
|
|
By:
|
|||
Name:
|
|||
Social
Security Number or Tax Identification Number:
|
|||
Date:
|
|
TO:
|
Cicero,
Inc.
|
|
By:
|
|||
Name:
|
|||
Social
Security Number or Tax Identification Number:
|
|||
Date:
|
Print
Name of Transferee:
|
Address:
|
City
State Zip Code
|
Security
or Federal Tax ID Number:
|
Dated:
|
Signature:
|
||
(Signature
must conform in all respects to name of Holder as specified on the face of
the
Warrant)
|
1.
|
Employment
. The
Company hereby employs Employee and Employee hereby accepts such
employment upon the terms and conditions set forth in this
Agreement.
|
2.
|
Duties of
Employee
. Employee will be based in New Jersey or North
Carolina at the discretion of the Company. Employee’s title
will be Chief Executive Officer, Chief Financial Officer, Chief Operating
Officer and Corporate Secretary and Employee will report directly to the
Board of Directors of the Company. Employee agrees
to perform and discharge such other duties as may be assigned to Employee
from time to time by the Company to the reasonable satisfaction of the
Board of Directors , and such duties will be consistent with those duties
regularly and customarily assigned by the Company to the position of Chief
Executive Officer, Chief Financial Officer and
Secretary. Employee agrees to comply with all of the Company's
policies, standards and regulations and to follow the instructions and
directives as promulgated by the Board of Directors of the
Company. Employee will devote Employee's full professional and
business-related time, skills and best efforts to such duties and will
not, during the term of this Agreement, be engaged (whether or not during
normal business hours) in any other business or professional activity,
whether or not such activity is pursued for gain, profit or other
pecuniary advantage, without the prior written consent of the Board of
Directors of the Company. This Section will not be construed to
prevent Employee from (a) investing personal assets in businesses which do
not compete with the Company in such form or manner that will not require
any services on the part of Employee in the operation or the affairs of
the companies in which such investments are made and in which Employee's
participation is solely that of an investor; (b) purchasing securities in
any corporation whose securities are listed on a national securities
exchange or regularly traded in the over-the-counter market, provided that
Employee at no time owns, directly or indirectly, in excess of one percent
(1%) of the outstanding stock of any class of any such corporation engaged
in a business competitive with that of the Company; or (c) participating
in conferences, preparing and publishing papers or books, teaching or
joining or participating in any professional associations or trade group,
so long as the Board of Directors of the Company approves such
participation, preparation and publication or teaching prior to Employee’s
engaging therein.
|
3.
|
Term
. The
term of this Agreement will be at-will, and can be terminated by either
party at any time, with or without cause, subject to the provisions of
Section 4 of this Agreement.
|
4.
|
Termination
.
|
|
(a)
|
Termination by Company
for Cause
. The Company may terminate this Agreement and
all of its obligations hereunder immediately, including the obligation to
pay Employee severance, vacation pay or any further accrued benefits or
remuneration, if any of the following events
occur:
|
|
(i)
|
Employee
materially breaches any of the terms or conditions set forth in this
Agreement and fails to cure such breach within ten (10) days after
Employee's receipt from the Company of written notice of such breach
(notwithstanding the foregoing, no cure period shall be applicable to
breaches by Employee of Sections 10 through 14 of this
Agreement);
|
|
(ii)
|
Employee
commits any other act materially detrimental to the business or reputation
of the Company;
|
|
(iii)
|
Employee
engages in dishonest or illegal activities or commits or is convicted of
any crime involving fraud, deceit or moral turpitude;
or
|
|
(iv)
|
Employee
dies or becomes mentally or physically incapacitated or disabled so as to
be unable to perform Employee's duties under this Agreement even with a
reasonable accommodation. Without limiting the generality of
the foregoing, Employee's inability adequately to perform services under
this Agreement for a period of sixty (60) consecutive days will be
conclusive evidence of such mental or physical incapacity or disability,
unless such inability is pursuant to a mental or physical
incapacity or disability covered by the Family Medical Leave Act, in which
case such sixty (60) day period shall be extended to a one hundred and
twenty (120) day period.
|
|
(b)
|
Termination by Company
Without Cause
. The Company may terminate Employee's
employment pursuant to this Agreement for reasons other than those stated
in Section 4(a) upon at least thirty (30) days' prior written notice to
Employee. In the event Employee's employment with the Company is
terminated by the Company without cause, the Company shall be obligated to
pay Employee a lump sum severance payment equal to twelve (12) months of
Employee’s then base salary payable within thirty (30)
days after the date of termination. In addition,
Employee will be entitled to payment of all unused vacation days at his
current daily rate and any accrued but unpaid salary or earned bonuses.
Any option grants or restricted stock awards made to employee will
immediately vest. The payment to Employee
for all deferred salaries and earned bonuses will be paid
within 30 days by the Company. Other than the severance payments set forth
in this Section 4(b), Employee will be entitled to receive no further
remuneration and will not be entitled to participate in any Company
benefit programs following his termination by the Company, whether such
termination is with or without
cause.
|
|
(c)
|
Termination by
Employee for Cause
. In the event of a Change of Control
(as defined below) of the Company that results in either a substantial
reduction or change of title in the Employee’s job duties related to his
position as CFO or CEO, ,or a decrease in or a failure to provide the
compensation or vested benefits under this Agreement or the Company
initiates a substantial reduction or change of title in the Employee’s job
duties related to his position as CFO, Employee shall have the right to
resign his employment and will be entitled to a lump sum severance payment
equal to twelve (12) months of Employee’s then base salary payable within
thirty (30) days after the date of termination In
addition, Employee will be entitled to payment of all unused vacation days
at his current daily rate and a lump sum equal to all deferred salaries
and earned bonuses. In addition, all Employee’s then outstanding but
unvested stock options shall vest one hundred percent
(100%). Employee shall have 12 months from the date written
notice is given to Employee about the announcement and closing of a
transaction resulting in a Change in Control of the Company that would
result in a substantial change in the Employee’s job duties or decrease
his compensation or vested benefits under this Agreement to resign or this
Section 4(c) shall not apply. In the event Employee resigns
from the Company for any other reason, Employee will not be entitled to
receive or accrue any further Company benefits or other remuneration under
this Agreement, and Employee specifically agrees that he will not be
entitled to receive any severance
pay.
|
|
(i)
|
the
merger or consolidation of the Company with or into another unaffiliated
entity, or the merger of another unaffiliated entity into the Company or
another subsidiary thereof with the effect that immediately after such
transaction the stockholders of the Company immediately prior to such
transaction hold less than fifty percent (50%) of the total voting power
of all securities generally entitled to vote in the election of directors,
managers or trustees of the entity surviving such merger or
consolidation. This provision will not apply to any
reorganization and reverse merger between the Company and any subsidiary
(or any other similar entity established for a similar
purpose);
|
|
(ii)
|
the
sale or transfer of more than fifty-one percent (51%) of the Company’s
then outstanding voting stock (other than a restructuring event which
results in the continuation of the Company’s business by an affiliated
entity) to unaffiliated person or group (as such term is used in Section
13(d)(3) of the Securities Exchange Act of 1934, as amended);
or
|
|
(iii)
|
the
adoption by the stockholders of the Company of a plan relating to the
liquidation or dissolution of the
Company.
|
|
(a)
|
Annual
Salary
. During the term of this Agreement and for all
services rendered by Employee under this Agreement, the Company will pay
Employee a base salary of One Hundred and Seventy-Five Thousand Dollars
($175,000.00) per annum in equal bi-monthly
installments. Employee will also be entitled to earn a short
term incentive compensation as further outlined in Exhibit
D.
|
|
(b)
|
Incentive
Compensation
. Employee is eligible for
an annual bonus upon the Company reaching certain pre tax
income levels (after accounting for all bonuses) as set forth
in Exhibit C. Said bonus will be payable after the annual
accounts have been presented to the Compensation Committee. Exhibit C
attached hereto provides the benchmarks associated with achieving the
Incentive Compensation.
|
|
(c)
|
Equity
Awards
. Employee is eligible for stock option grants and
restricted stock awards as determined by the Compensation
Committee.
|
6.
|
Vacation.
Employee
shall be eligible for four (4) weeks of paid vacation annually, provided
that such vacation is scheduled at such times that do not interfere with
the Company’s legitimate business
needs.
|
7.
|
Other
Benefits
. Employee will be entitled to such fringe
benefits as may be provided from time-to-time by the Company to its
employees, including, but not limited to, group health insurance, life and
disability insurance, and any other fringe benefits now or hereafter
provided by the Company to its employees, if and when Employee meets the
eligibility requirements for any such benefit. The Company
reserves the right to change or discontinue any employee benefit plans or
programs now being offered to its employees; provided, however, that all
benefits provided for employees of the same position and status as
Employee will be provided to Employee on an equal
basis.
|
8.
|
Business
Expenses
. Employee will be reimbursed for all reasonable
expenses incurred in the discharge of Employee's duties under this
Agreement pursuant to the Company's standard reimbursement
policies.
|
9.
|
Withholding
. The
Company will deduct and withhold from the payments made to Employee under
this Agreement, state and federal income taxes, FICA and other amounts
normally withheld from compensation due
employees.
|
10.
|
Non-Disclosure of
Proprietary Information
. Employee recognizes and
acknowledges that the Trade Secrets (as defined below) and Confidential
Information (as defined below) of the Company and its affiliates and all
physical embodiments thereof (as they may exist from time-to-time,
collectively, the “Proprietary Information”) are valuable, special and
unique assets of the Company's and its affiliates' businesses. Employee
further acknowledges that access to such Proprietary Information is
essential to the performance of Employee's duties under this
Agreement. Therefore, in order to obtain access to such
Proprietary Information, Employee agrees that, except with respect to
those duties assigned to him by the Company, Employee will hold
in confidence all Proprietary Information and will not reproduce, use,
distribute, disclose, publish or otherwise disseminate any Proprietary
Information, in whole or in part, and will take no action causing, or fail
to take any action necessary to prevent causing, any Proprietary
Information to lose its character as Proprietary Information, nor will
Employee make use of any such information for Employee's own purposes or
for the benefit of any person, firm, corporation, association or other
entity (except the Company) under any
circumstances.
|
11.
|
Non-Solicitation
Covenants
. Employee agrees that during Employee's
employment by the Company and for a period of two (2) year
following the termination of Employee's employment for whatever reason,
Employee will not, directly or indirectly, on Employee's own behalf or in
the service of or on behalf of any other individual or entity, divert,
solicit or attempt to divert or solicit any individual or entity (i) who
is a client of the Company at any time during the six (6)-month period
prior to Employee's termination of employment with the Company (“Client”),
or was actively sought by the Company as a prospective client, and (ii)
with whom Employee had material contact while employed by the Company to
provide similar services or products as such provided by
Employee for the Company to such Clients or prospects. Employee
further agrees and represents that during Employee's employment by the
Company and for a period of two (2) year following any
termination of Employee's employment for whatever reason, Employee will
not, directly or indirectly, on Employee's own behalf or in the service
of, or on behalf of any other individual or entity, divert, solicit or
hire away, or attempt to divert, solicit or hire away, to or for any
individual or entity which is engaged in providing similar services or
products to that provided by the Company, any person employed by the
Company for whom Employee had supervisory responsibility or with whom
Employee had material contact while employed by the Company, whether or
not such employee is a full-time employee or temporary employee of the
Company, whether or not such employee is employed pursuant to written
agreement and whether or not such employee is employed for a determined
period or at-will. For purposes of this Agreement, “material
contact” exists between Employee and a Client or potential Client when (1)
Employee established and/or nurtured the Client or potential Client; (2)
the Client or potential Client and Employee interacted to further a
business relationship or contract with the Company; (3) Employee had
access to confidential information and/or marketing strategies or programs
regarding the Client or potential Client; and/or (4) Employee learned of
the Client or potential Client through the efforts of the Company
providing Employee with confidential Client information, including but not
limited to the Client’s identify, for purposes of furthering a business
relationship.
|
12.
|
Existing Restrictive
Covenants
. Except as provided in Exhibit B, Employee has
not entered into any agreement with any employer or former employer: (a)
to keep in confidence any confidential information, or (b) to not compete
with any former employer. Employee represents and warrants that
Employee's employment with the Company does not and will not breach any
agreement which Employee has with any former employer to keep in
confidence confidential information or not to compete with any such former
employer. Employee will not disclose to the Company or use on
its behalf any confidential information of any other party required to be
kept confidential by Employee.
|
13.
|
Return of Proprietary
Information
. Employee acknowledges that as a result of
Employee's employment with the Company, Employee may come into the
possession and control of Proprietary Information, such as proprietary
documents, drawings, specifications, manuals, notes, computer programs, or
other proprietary material. Employee acknowledges, warrants and
agrees that Employee will return to the Company all such items and any
copies or excerpts thereof, and any other properties, files or documents
obtained as a result of Employee's employment with the Company,
immediately upon the termination of Employee's employment with the
Company.
|
14.
|
Proprietary
Rights
. During the course of Employee's employment with
the Company, Employee may make, develop or conceive of useful processes,
machines, compositions of matter, computer software, algorithms, works of
authorship expressing such algorithm, or any other discovery, idea,
concept, document or improvement which relates to or is useful to the
Company's Business (the “Inventions”), whether or not subject to copyright
or patent protection, and which may or may not be considered Proprietary
Information. Employee acknowledges that all such Inventions
will be “works made for hire” under United States copyright law and will
remain the sole and exclusive property of the Company. Employee
also hereby assigns and agrees to assign to the Company, in perpetuity,
all right, title and interest Employee may have in and to such Inventions,
including without limitation, all copyrights, and the right to apply for
any form of patent, utility model, industrial design or similar
proprietary right recognized by any state, country or
jurisdiction. Employee further agrees, at the Company's request
and expense, to do all things and sign all documents or instruments
necessary, in the opinion of the Company, to eliminate any ambiguity as to
the ownership of, and rights of the Company to, such Inventions, including
filing copyright and patent registrations and defending and enforcing in
litigation or otherwise all such
rights.
|
15.
|
Remedies
. Employee
agrees and acknowledges that the violation of any of the covenants or
agreements contained in Sections 10 through 14 of this Agreement would
cause irreparable injury to the Company, that the remedy at law for any
such violation or threatened violation thereof would be inadequate, and
that the Company will be entitled, in addition to any other remedy, to
temporary and permanent injunctive or other equitable relief without the
necessity of proving actual damages or posting a
bond.
|
16.
|
Severability
. In
case one or more of the provisions contained in this Agreement is for any
reason held to be invalid, illegal or unenforceable in any respect, the
parties agree that it is their intent that the same will not affect any
other provision in this Agreement, and this Agreement will be construed as
if such invalid or illegal or unenforceable provision had never been
contained herein. It is the intent of the parties that this
Agreement be enforced to the maximum extent permitted by
law.
|
17.
|
Entire
Agreement
. This Agreement embodies the entire agreement
of the parties relating to the subject matter of this Agreement and
supersedes all prior agreements, oral or written, regarding the subject
matter hereof. No amendment or modification of this
Agreement will be valid or binding upon the parties unless made in writing
and signed by the parties.
|
18.
|
Governing
Law
. This Agreement is entered into and will be
interpreted and enforced pursuant to the laws of the State of New
Jersey. The parties hereto hereby agree that the appropriate
forum and venue for any disputes between any of the parties hereto arising
out of this Agreement shall be any federal court in the state where the
Employee has his principal place of residence and each of the parties
hereto hereby submits to the personal jurisdiction of any such
court. The foregoing shall not limit the rights of any party to
obtain execution of judgment in any other jurisdiction. The
parties further agree, to the extent permitted by law, that a final and
unappealable judgment against either of them in any action or proceeding
contemplated above shall be conclusive and may be enforced in any other
jurisdiction within or outside the United States by suit on the judgment,
a certified exemplified copy of which shall be conclusive evidence of the
fact and amount of such judgment.
|
19.
|
Surviving
Terms
. Sections 4, 10, 11, 14, 15 and 18 of this
Agreement shall survive termination of this
Agreement.
|
COMPANY: |
EMPLOYEE:
|
||
CICERO, INC. | |||
By:
|
|
||
Name:
|
|
John
P. Broderick
|
|
Title:
|
|
Employee
represents that there are no Inventions.
|
||
___________________ | ||
Employee
Initials
|
Operating
Net Income Net Income Range (before tax)
|
||||||||||||
From
|
To
|
Variable
Compensation
|
||||||||||
Less
than $1,000,000
|
None
|
|||||||||||
Tier
1
|
$ | $1,000,000 | $ | 1,499,999 | $ | 100,000 | ||||||
Tier
2
|
$ | 1,500,000 | $ | 1,999,999 | $ | 200,000 | ||||||
Tier
3
|
greater
than $2,000,000
|
$ | 300,000 |
Up to US $ 500,000.00 |
November 3,
2008
|
CICERO,
INC.
|
By:
|
/s/ John Broderick | |
John
Broderick,
|
||
Chief Executive Officer | ||
Address: | ||
8000 Regency Parkway | ||
Suite 542 | ||
Cary, NC 27518 |
1.
|
Employment
. The
Company hereby employs Employee and Employee hereby accepts such
employment upon the terms and conditions set forth in this
Agreement.
|
2.
|
Duties of
Employee
. Employee will be based in New Jersey or North
Carolina at the discretion of the Company. Employee’s title
will be Chief Executive Officer, Chief Financial Officer, Chief Operating
Officer and Corporate Secretary and Employee will report directly to the
Board of Directors of the Company. Employee agrees
to perform and discharge such other duties as may be assigned to Employee
from time to time by the Company to the reasonable satisfaction of the
Board of Directors , and such duties will be consistent with those duties
regularly and customarily assigned by the Company to the position of Chief
Executive Officer, Chief Financial Officer and
Secretary. Employee agrees to comply with all of the Company's
policies, standards and regulations and to follow the instructions and
directives as promulgated by the Board of Directors of the
Company. Employee will devote Employee's full professional and
business-related time, skills and best efforts to such duties and will
not, during the term of this Agreement, be engaged (whether or not during
normal business hours) in any other business or professional activity,
whether or not such activity is pursued for gain, profit or other
pecuniary advantage, without the prior written consent of the Board of
Directors of the Company. This Section will not be construed to
prevent Employee from (a) investing personal assets in businesses which do
not compete with the Company in such form or manner that will not require
any services on the part of Employee in the operation or the affairs of
the companies in which such investments are made and in which Employee's
participation is solely that of an investor; (b) purchasing securities in
any corporation whose securities are listed on a national securities
exchange or regularly traded in the over-the-counter market, provided that
Employee at no time owns, directly or indirectly, in excess of one percent
(1%) of the outstanding stock of any class of any such corporation engaged
in a business competitive with that of the Company; or (c) participating
in conferences, preparing and publishing papers or books, teaching or
joining or participating in any professional associations or trade group,
so long as the Board of Directors of the Company approves such
participation, preparation and publication or teaching prior to Employee’s
engaging therein.
|
3.
|
Term
. The
term of this Agreement will be at-will, and can be terminated by either
party at any time, with or without cause, subject to the provisions of
Section 4 of this Agreement.
|
4.
|
Termination
.
|
|
(a)
|
Termination by Company
for Cause
. The Company may terminate this Agreement and
all of its obligations hereunder immediately, including the obligation to
pay Employee severance, vacation pay or any further accrued benefits or
remuneration, if any of the following events
occur:
|
|
(i)
|
Employee
materially breaches any of the terms or conditions set forth in this
Agreement and fails to cure such breach within ten (10) days after
Employee's receipt from the Company of written notice of such breach
(notwithstanding the foregoing, no cure period shall be applicable to
breaches by Employee of Sections 10 through 14 of this
Agreement);
|
|
(ii)
|
Employee
commits any other act materially detrimental to the business or reputation
of the Company;
|
|
(iii)
|
Employee
engages in dishonest or illegal activities or commits or is convicted of
any crime involving fraud, deceit or moral turpitude;
or
|
|
(iv)
|
Employee
dies or becomes mentally or physically incapacitated or disabled so as to
be unable to perform Employee's duties under this Agreement even with a
reasonable accommodation. Without limiting the generality of
the foregoing, Employee's inability adequately to perform services under
this Agreement for a period of sixty (60) consecutive days will be
conclusive evidence of such mental or physical incapacity or disability,
unless such inability is pursuant to a mental or physical
incapacity or disability covered by the Family Medical Leave Act, in which
case such sixty (60) day period shall be extended to a one hundred and
twenty (120) day period.
|
|
(b)
|
Termination by Company
Without Cause
. The Company may terminate Employee's
employment pursuant to this Agreement for reasons other than those stated
in Section 4(a) upon at least thirty (30) days' prior written notice to
Employee. In the event Employee's employment with the Company is
terminated by the Company without cause, the Company shall be obligated to
pay Employee a lump sum severance payment equal to twelve (12) months of
Employee’s then base salary payable within thirty (30)
days after the date of termination. In addition,
Employee will be entitled to payment of all unused vacation days at his
current daily rate and any accrued but unpaid salary or earned bonuses.
Any option grants or restricted stock awards made to employee will
immediately vest. The payment to Employee
for all deferred salaries and earned bonuses will be paid
within 30 days by the Company. Other than the severance payments set forth
in this Section 4(b), Employee will be entitled to receive no further
remuneration and will not be entitled to participate in any Company
benefit programs following
his
termination by the Company, whether such termination is with or without
cause.
|
|
(c)
|
Termination by
Employee for Cause
. In the event of a Change of Control
(as defined below) of the Company that results in either a substantial
reduction or change of title in the Employee’s job duties related to his
position as CFO or CEO, ,or a decrease in or a failure to provide the
compensation or vested benefits under this Agreement or the Company
initiates a substantial reduction or change of title in the Employee’s job
duties related to his position as CFO, Employee shall have the right to
resign his employment and will be entitled to a lump sum severance payment
equal to twelve (12) months of Employee’s then base salary payable within
thirty (30) days after the date of termination In
addition, Employee will be entitled to payment of all unused vacation days
at his current daily rate and a lump sum equal to all deferred salaries
and earned bonuses. In addition, all Employee’s then outstanding but
unvested stock options shall vest one hundred percent
(100%). Employee shall have 12 months from the date written
notice is given to Employee about the announcement and closing of a
transaction resulting in a Change in Control of the Company that would
result in a substantial change in the Employee’s job duties or decrease
his compensation or vested benefits under this Agreement to resign or this
Section 4(c) shall not apply. In the event Employee resigns
from the Company for any other reason, Employee will not be entitled to
receive or accrue any further Company benefits or other remuneration under
this Agreement, and Employee specifically agrees that he will not be
entitled to receive any severance
pay.
|
|
(i)
|
the
merger or consolidation of the Company with or into another unaffiliated
entity, or the merger of another unaffiliated entity into the Company or
another subsidiary thereof with the effect that immediately after such
transaction the stockholders of the Company immediately prior to such
transaction hold less than fifty percent (50%) of the total voting power
of all securities generally entitled to vote in the election of directors,
managers or trustees of the entity surviving such merger or
consolidation. This provision will not apply to any
reorganization and reverse merger between the Company and any subsidiary
(or any other similar entity established for a similar
purpose);
|
|
(ii)
|
the
sale or transfer of more than fifty-one percent (51%) of the Company’s
then outstanding voting stock (other than a restructuring event which
results in the continuation of the Company’s business by an affiliated
entity) to unaffiliated person or group (as such term is used in Section
13(d)(3) of the Securities Exchange Act of 1934, as amended);
or
|
|
(iii)
|
the
adoption by the stockholders of the Company of a plan relating to the
liquidation or dissolution of the
Company.
|
|
(a)
|
Annual
Salary
. During the term of this Agreement and for all
services rendered by Employee under this Agreement, the Company will pay
Employee a base salary of One Hundred and Seventy-Five Thousand Dollars
($175,000.00) per annum in equal bi-monthly
installments. Employee will also be entitled to earn a short
term incentive compensation as further outlined in Exhibit
D.
|
|
(b)
|
Incentive
Compensation
. Employee is eligible for
an annual bonus upon the Company reaching certain pre tax
income levels (after accounting for all bonuses) as set forth
in Exhibit C. Said bonus will be payable after the annual
accounts have been presented to the Compensation Committee. Exhibit C
attached hereto provides the benchmarks associated with achieving the
Incentive Compensation.
|
|
(c)
|
Equity
Awards
. Employee is eligible for stock option grants and
restricted stock awards as determined by the Compensation
Committee.
|
6.
|
Vacation.
Employee
shall be eligible for four (4) weeks of paid vacation annually, provided
that such vacation is scheduled at such times that do not interfere with
the Company’s legitimate business
needs.
|
7.
|
Other
Benefits
. Employee will be entitled to such fringe
benefits as may be provided from time-to-time by the Company to its
employees, including, but not limited to, group health insurance, life and
disability insurance, and any other fringe benefits now or hereafter
provided by the Company to its employees, if and when Employee meets the
eligibility requirements for any such benefit. The Company
reserves the right to change or discontinue any employee benefit plans or
programs now being offered to its employees; provided, however, that all
benefits provided for employees of the same position and status as
Employee will be provided to Employee on an equal
basis.
|
8.
|
Business
Expenses
. Employee will be reimbursed for all reasonable
expenses incurred in the discharge of Employee's duties under this
Agreement pursuant to the Company's standard reimbursement
policies.
|
9.
|
Withholding
. The
Company will deduct and withhold from the payments made to Employee under
this Agreement, state and federal income taxes, FICA and other amounts
normally withheld from compensation due
employees.
|
10.
|
Non-Disclosure of
Proprietary Information
. Employee recognizes and
acknowledges that the Trade Secrets (as defined below) and Confidential
Information (as defined below) of the Company and its affiliates and all
physical embodiments thereof (as they may exist from time-to-time,
collectively, the “Proprietary Information”) are valuable, special and
unique assets of the Company's and its affiliates' businesses. Employee
further acknowledges that access to such Proprietary Information is
essential to the performance
|
|
of
Employee's duties under this Agreement. Therefore, in order to
obtain access to such Proprietary Information, Employee agrees that,
except with respect to those duties assigned to him by the Company,
Employee will hold in confidence all Proprietary Information
and will not reproduce, use, distribute, disclose, publish or otherwise
disseminate any Proprietary Information, in whole or in part, and will
take no action causing, or fail to take any action necessary to prevent
causing, any Proprietary Information to lose its character as Proprietary
Information, nor will Employee make use of any such information for
Employee's own purposes or for the benefit of any person, firm,
corporation, association or other entity (except the Company) under any
circumstances.
|
11.
|
Non-Solicitation
Covenants
. Employee agrees that during Employee's
employment by the Company and for a period of two (2) year
following the termination of Employee's employment for whatever reason,
Employee will not, directly or indirectly, on Employee's own behalf or in
the service of or on behalf of any other individual or entity, divert,
solicit or attempt to divert or solicit any individual or entity (i) who
is a client of the Company at any time during the six (6)-month period
prior to Employee's termination of employment with the Company (“Client”),
or was actively sought by the Company as a prospective client, and (ii)
with whom Employee had material contact while employed by the Company to
provide similar services or products as such provided by
Employee for the Company to such Clients or prospects. Employee
further agrees and represents that during Employee's employment by the
Company and for a period of two (2) year following any
termination of Employee's employment for whatever reason, Employee will
not, directly or indirectly, on Employee's own behalf or in the service
of, or on behalf
of
any other individual or entity, divert, solicit or hire away, or attempt
to divert, solicit or hire away, to or for any individual or entity which
is engaged in providing similar services or products to that provided by
the Company, any person employed by the Company for whom Employee had
supervisory responsibility or with whom Employee had material contact
while employed by the Company, whether or not such employee is a full-time
employee or temporary employee of the Company, whether or not such
employee is employed pursuant to written agreement and whether or not such
employee is employed for a determined period or at-will. For
purposes of this Agreement, “material contact” exists between Employee and
a Client or potential Client when (1) Employee established and/or nurtured
the Client or potential Client; (2) the Client or potential Client and
Employee interacted to further a business relationship or contract with
the Company; (3) Employee had access to confidential information and/or
marketing strategies or programs regarding the Client or potential Client;
and/or (4) Employee learned of the Client or potential Client through the
efforts of the Company providing Employee with confidential Client
information, including but not limited to the Client’s identify, for
purposes of furthering a business
relationship.
|
12.
|
Existing Restrictive
Covenants
. Except as provided in Exhibit B, Employee has
not entered into any agreement with any employer or former employer: (a)
to keep in confidence any confidential information, or (b) to not compete
with any former employer. Employee represents and warrants that
Employee's employment with the Company does not and will not breach any
agreement which Employee has with any former employer to keep in
confidence confidential information or not to compete with any such former
employer. Employee will not disclose to the Company or use on
its behalf any confidential information of any other party required to be
kept confidential by Employee.
|
13.
|
Return of Proprietary
Information
. Employee acknowledges that as a result of
Employee's employment with the Company, Employee may come into the
possession and control of Proprietary Information, such as proprietary
documents, drawings, specifications, manuals, notes, computer programs, or
other proprietary material. Employee acknowledges, warrants and
agrees that Employee will return to the Company all such items and any
copies or excerpts thereof, and any other properties, files or documents
obtained as a result of Employee's employment with the Company,
immediately upon the termination of Employee's employment with the
Company.
|
14.
|
Proprietary
Rights
. During the course of Employee's employment with
the Company, Employee may make, develop or conceive of useful processes,
machines, compositions of matter, computer software, algorithms, works of
authorship expressing such algorithm, or any other discovery, idea,
concept, document or improvement which relates to or is useful to the
Company's Business (the “Inventions”), whether or not subject to copyright
or patent protection, and which may or may not be considered Proprietary
Information. Employee acknowledges that all such Inventions
will be “works made for hire” under United States copyright law and will
remain the sole and exclusive property of the Company. Employee
also hereby assigns and agrees to assign to the Company, in perpetuity,
all right, title and interest Employee may have in and to such Inventions,
including without limitation, all copyrights, and the right to apply for
any form of patent,
utility
model, industrial design or similar proprietary right recognized by any
state, country or jurisdiction. Employee further agrees, at the
Company's request and expense, to do all things and sign all documents or
instruments necessary, in the opinion of the Company, to eliminate any
ambiguity as to the ownership of, and rights of the Company to, such
Inventions, including filing copyright and patent registrations and
defending and enforcing in litigation or otherwise all such
rights.
|
15.
|
Remedies
. Employee
agrees and acknowledges that the violation of any of the covenants or
agreements contained in Sections 10 through 14 of this Agreement would
cause irreparable injury to the Company, that the remedy at law for any
such violation or threatened violation thereof would be inadequate, and
that the Company will be entitled, in addition to any other remedy, to
temporary and permanent injunctive or other equitable relief without the
necessity of proving actual damages or posting a
bond.
|
16.
|
Severability
. In
case one or more of the provisions contained in this Agreement is for any
reason held to be invalid, illegal or unenforceable in any respect, the
parties agree that it is their intent that the same will not affect any
other provision in this Agreement, and this Agreement will be construed as
if such invalid or illegal or unenforceable provision had never been
contained herein. It is the intent of the parties that this
Agreement be enforced to the maximum extent permitted by
law.
|
17.
|
Entire
Agreement
. This Agreement embodies the entire agreement
of the parties relating to the subject matter of this Agreement and
supersedes all prior agreements, oral or written, regarding the subject
matter hereof. No amendment or modification of this
Agreement will be valid or binding upon the parties unless made in writing
and signed by the parties.
|
18.
|
Governing
Law
. This Agreement is entered into and will be
interpreted and enforced pursuant to the laws of the State of New
Jersey. The parties hereto hereby agree that the appropriate
forum and venue for any disputes between any of the parties hereto arising
out of this Agreement shall be any federal court in the state where the
Employee has his principal place of residence and each of the parties
hereto hereby submits to the personal jurisdiction of any such
court. The foregoing shall not limit the rights of any party to
obtain execution of judgment in any other jurisdiction. The
parties further agree, to the extent permitted by law, that a final and
unappealable judgment against either of them in any action or proceeding
contemplated above shall be conclusive and may be enforced in any other
jurisdiction within or outside the United States by suit on the judgment,
a certified exemplified copy of which shall be conclusive evidence of the
fact and amount of such judgment.
|
19.
|
Surviving
Terms
. Sections 4, 10, 11, 14, 15 and 18 of this
Agreement shall survive termination of this
Agreement.
|
Employee
represents that there are no
Inventions.
|
___________________ | |
Employee
Initials
|
Operating
Net Income Net Income Range (before tax)
|
||||||||||||
From
|
To
|
Variable
Compensation
|
||||||||||
Less
than $1,000,000
|
None
|
|||||||||||
Tier
1
|
$ | 1,000,000 | $ | 1,699,999 | $ | 100,000 | ||||||
Tier
2
|
$ | 1,700,000 | $ | 1,999,999 | $ | 200,000 | ||||||
Tier
3
|
greater
than $2,000,000
|
$ | 300,000 | |||||||||
CICERO,
I NC.
|
||
By:
|
|
|
Name:
John Broderick
|
||
Title:
Chief Executive Officer
|
/s/Margolis
& Company P.C.
|
|
Certified
Public Accountants
|
2.
|
Based
on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this
report;
|
3.
|
Based
on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this
report;
|
4.
|
I
am responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and
internal control over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f)) for the registrant and
have:
|
|
a)
|
designed
such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure
that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being
prepared;
|
|
b)
|
designed
such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting
principals;
|
|
c)
|
evaluated
the effectiveness of the registrant's disclosure controls and procedures
and presented in this report our conclusions about the effectiveness of
the disclosure controls and procedures, as of the end of the period
covered by this report based upon such evaluation;
and
|
|
d)
|
disclosed
in this report any change in the registrant’s internal control over
financial reporting that occurred during the registrant’s most recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant’s internal control over financial
reporting; and
|
5.
|
I
have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrant's auditors and the audit
committee of the registrant's board of directors (or persons performing
the equivalent functions):
|
|
a)
|
all
significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant’s ability to record,
process, summarize and report financial information;
and
|
|
b)
|
any
fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control
over financial reporting.
|
Date:
March 31, 2009
|
/s/ John P. Broderick
|
John
P. Broderick
|
|
Chief
Executive Officer
|
2.
|
Based
on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this
report;
|
3.
|
Based
on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this
report;
|
4.
|
I
am responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and
internal control over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f)) for the registrant and
have:
|
|
a)
|
designed
such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure
that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being
prepared;
|
|
b)
|
designed
such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting
principals;
|
|
c)
|
evaluated
the effectiveness of the registrant's disclosure controls and procedures
and presented in this report our conclusions about the effectiveness of
the disclosure controls and procedures, as of the end of the period
covered by this report based upon such evaluation;
and
|
|
d)
|
disclosed
in this report any change in the registrant’s internal control over
financial reporting that occurred during the registrant’s most recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant’s internal control over financial
reporting; and
|
5.
|
I
have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrant's auditors and the audit
committee of the registrant's board of directors (or persons performing
the equivalent functions):
|
|
a)
|
all
significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant’s ability to record,
process, summarize and report financial information;
and
|
|
b)
|
any
fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control
over financial reporting.
|
Date:
March 31, 2009
|
/s/ John P. Broderick
|
John
P. Broderick
|
|
Chief
Financial Officer
|
(1)
|
The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the
Securities
Exchange Act of 1934; and
|
|
|
(2)
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company
for the periods presented in the
Report.
|
By: |
/s/ John P.
Broderick
|
|
John P. Broderick | ||
Chief Executive and Financial Officer | ||
(Principal Financial and Accounting Officer) | ||
March 31, 2009 |